Effectiveness and Safety of Probiotics in Protecting Liver Function

Exclusion Criteria

• •1. Patients with various types of viral hepatitis, autoimmune liver disease, drug-induced liver damage, vascular liver disease, genetic metabolic liver disease, or primary liver cancer;
• •2. Individuals who have recently consumed substances with similar functions to the tested product, potentially affecting the study results;
• •3. Patients with severe allergies or immune deficiencies;
• •4. Pregnant, breastfeeding, or women with plans for pregnancy;
• •5. Individuals with severe diseases of vital organs such as cardiovascular, pulmonary, hepatic, renal conditions, or those with diabetes, severe thyroid disorders, metabolic diseases, malignant tumors, or severe immune system disorders;
• •6. Individuals who have used antibiotics within the past two weeks;
• •7. Participants who did not comply with the required consumption of the tested product or missed follow-ups, making it impossible to evaluate the effectiveness;
• •8. Other participants deemed unsuitable by the researchers.